-
1 Comment
Tus-Pharmaceutical Group Co., Ltd is currently in a long term uptrend where the price is trading 3.6% above its 200 day moving average.
From a valuation standpoint, the stock is 29.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.8.
Tus-Pharmaceutical Group Co., Ltd's total revenue sank by 2.3% to $98M since the same quarter in the previous year.
Its net income has dropped by 86.5% to $3M since the same quarter in the previous year.
Finally, its free cash flow fell by 1175.9% to $-13M since the same quarter in the previous year.
Based on the above factors, Tus-Pharmaceutical Group Co., Ltd gets an overall score of 2/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE000000701 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Dividend Yield | None |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Beta | 0.22 |
Tus-Pharmaceutical Group Co., Ltd. manufactures and sells Chinese patent medicines, chemical medicines, and health foods in China. It offers prescription and over-the-counter drugs, such as tonic and health care, cardiovascular and cerebrovascular, children's nutrition, cold, and heat-clearing and detoxifying drugs. The company was formerly known as Tus-Guhan Group Corp.,Ltd. Tus-Pharmaceutical Group Co., Ltd. was founded in 1956 and is headquartered in Hengyang, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 000590.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
